Atıf İçin Kopyala
Demirci N. S., AKSOY S., ÖZDEMİR N., Erdem G. U., Ozcelik M., Tanrikulu E., ...Daha Fazla
CURRENT MEDICAL RESEARCH AND OPINION, cilt.33, sa.3, ss.401-407, 2017 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
33
Sayı:
3
-
Basım Tarihi:
2017
-
Doi Numarası:
10.1080/03007995.2016.1257984
-
Dergi Adı:
CURRENT MEDICAL RESEARCH AND OPINION
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.401-407
-
Anahtar Kelimeler:
Cisplatin, docetaxel, fluorouracil, head and neck, cancer, metastasis, modified DCF, recurrence, COOPERATIVE-ONCOLOGY-GROUP, MULTICENTER PHASE-II, METASTATIC HEAD, PLUS CETUXIMAB, RANDOMIZED-TRIAL, OPEN-LABEL, RECURRENT, CHEMOTHERAPY, 5-FLUOROURACIL, METHOTREXATE
-
Marmara Üniversitesi Adresli:
Evet
Özet
Aim: Modified docetaxel, cisplatin, and 5-fluorouracil (mDCF) therapy has been shown to be a well tolerated and highly effective regimen for metastatic gastric carcinoma. Herein we investigated the effectiveness of the mDCF combination as the first-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck (HNSCC).